STUDY OF THE PREVALENCE OF GLUCOCORTICOSTEROID OSTEOPOROSIS IN PATIENTS WITH ACANTHOLYTIC PEMPHIGUS

Authors

  • Guzal Davlyatovna Klebleyeva
  • Akbar Jurakulovich Utayev
  • Davlat Mukumovich Abdullaev

Keywords:

pemphigus, treatment

Abstract

The aim of the study was to study the prevalence of glucocorticosteroid osteoporosis in patients with acantholytic pemphigus and the risk development of osteoporotic fractures. 26 patients with bullous dermatitis were examined . toses , including 12 patients with acantholytic pemphigus (AP). Diagnosis The AP was installed in accordance with the standard of providing specialized care. Noah medical help sick pemphigus, Group comparisons compiled 14 sick others vesicular dermatoses (herpetiformis dermatitis Dühring, bullous pemphigoid Levera , family benign pu - phiuchus Gougereau-Haley-Haley, toxicoderma ). Glucocorticosteroid osteoporosis diagnosed at 33.3% sick AP, receiving glucocorticosteroid therapy, osteopenia more in 33.3% of such patients, with an increased risk of developing osteoporosis and - fractures were observed in all patients with AP over 40 years of age, which requires early diagnostics pathological changes bone fabrics And prevention complications such as osteoporotic fractures. The high proportion complications (83.3%) from taking systemic GCS necessitate inclusion in the examination plan of patients with AP mineral analysis bone density and osteoporotic fracture risk analysis by mo - FRAX, as well as improving the continuity of dermatologists with related specialists.

References

Хамраева Г., Абдуллаев Х., Нуруллаева Д. Оптимизация седации при малоинвазивных хирургических манипуляциях у детей с онкогематологическими заболеваниями //in Library. – 2024. – Т. 2. – №. 2. – С. 518-524.

Utayev A. J. et al. FRESH PERSPECTIVE ON THE PROGRESSION OF SEXUALLY TRANSMITTED INFECTIONS //GOLDEN BRAIN. – 2024. – Т. 2. – №. 5. – С. 140-145.

Ruziyev K. T. et al. ENZYME IMMUNOASSAY FOR SERORESISTANT SYPHILIS VARIANTS //GOLDEN BRAIN. – 2024. – Т. 2. – №. 5. – С. 158-164.

Utayev A. J. et al. TO EVALUATE THE PATHOGENESIS OF ATOPIC DERMATITIS: THE ROLE OF GENETIC FACTORS //GOLDEN BRAIN. – 2024. – Т. 2. – №. 5. – С. 101-106.

Utayev A. J. et al. EXPERIENTIAL PERSPECTIVE ON THE APPLICATION OF TACROLIMUS IN ATOPIC DERMATITIS TREATMENT //GOLDEN BRAIN. – 2024. – Т. 2. – №. 5. – С. 151-157.

Ruziyev K. T. et al. COMBINATIVE TREATING METHODS FOR PAPILLOMAVIRUS INFECTION //GOLDEN BRAIN. – 2024. – Т. 2. – №. 5. – С. 122-127.

Utayev A. J. et al. UTILIZATION OF SEVORAN IN MANAGING LICHEN PLANUS: AN EXPERIENTIAL PERSPECTIVE //GOLDEN BRAIN. – 2024. – Т. 2. – №. 5. – С. 146-150.

Ruziyev K. T. et al. PROMOTING A WELL-ROUNDED LIFESTYLE FOR SCHOOL KIDS AND COLLEGE STUDENTS //GOLDEN BRAIN. – 2024. – Т. 2. – №. 5. – С. 134-139.

Ruziyev K. T. et al. WHEN PATIENTS RECEIVE A FORMAL DIAGNOSIS OF HERPES, THE PRESENCE OF ANTIBODIES TO HIV INFECTION IS OBSERVED //GOLDEN BRAIN. – 2024. – Т. 2. – №. 5. – С. 128-133.

Ruziyev K. T. et al. INVESTIGATION OF THE MICROELEMENT CONTENT OF PATIENTS’HAIR WITH DIFFUSE ALOPECIA //GOLDEN BRAIN. – 2024. – Т. 2. – №. 5. – С. 116-121.

Ruziyev K. T. et al. EXAMINING GENETIC POLYMORPHISM IN INDIVIDUALS WITH VIRAL IMMUNITY //GOLDEN BRAIN. – 2024. – Т. 2. – №. 5. – С. 107-115.

Downloads

Published

2024-10-26